A phase II study of weekly paclitaxel for advanced or recurrent esophageal cancer
Phase 2
- Conditions
- advanced or reccurent esophageal cancer
- Registration Number
- JPRN-UMIN000009807
- Lead Sponsor
- Medical Oncology, Hirosaki University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
severe bone marrow suppression active infection uncontrolled comorbidities acute inflammatory disease interstitial pneumonia or pulmonary fibrosis symptomatic metastases of the central nervous system with a history of allergic reaction to polyoxyethylene-castor oil under administration of disulfiram, cyanamide and procarbazine hydrochloride pregnant or nursing woman any patients judged by the investigator to be unfit to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate
- Secondary Outcome Measures
Name Time Method